1957235-75-4
Chemical Structure
Thalidomide-O-amido-PEG2-C2-NH2 TFA
Synonym(s): Cereblon Ligand-Linker Conjugates 10 TFA; E3 Ligase Ligand-Linker Conjugates 24 TFA
- CAS No.: 1957235-75-4
- Formula:C23H27F3N4O10
- Molecular Weight:576.48
IUPAC Name: N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate
InChIKey: JQWXWSIQGKGHEB-UHFFFAOYSA-N
SMILES: O=C(NCCOCCOCCN)COC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.O=C(O)C(F)(F)F
Biological Activity: Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Thalidomide-O-amido-PEG2-C2-NH2 TFA | 99.72% | Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
